Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer
In physiological conditions, the activity of the intestinal immune system is tightly regulated to prevent tissue-damaging reactions directed against components of the luminal flora. Various factors contribute to maintain immune homeostasis and diminished production and/or function of such molecules...
Main Authors: | Edoardo Troncone, Irene Marafini, Carmine Stolfi, Giovanni Monteleone |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01407/full |
Similar Items
-
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer
by: Carmine Stolfi, et al.
Published: (2020-12-01) -
Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials
by: Giovanni Monteleone, et al.
Published: (2022-12-01) -
Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer
by: Edoardo Troncone, et al.
Published: (2021-04-01) -
Smad7 and Colorectal Carcinogenesis: A Double-Edged Sword
by: Edoardo Troncone, et al.
Published: (2019-05-01) -
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
by: Davide Di Fusco, et al.
Published: (2019-03-01)